Gemsomax Softgel Capsule is a combination pharmaceutical formulation containing Calcitriol (0.25 mcg), Calcium Carbonate (500 mg), and Zinc Sulfate (7.5 mg), designed to support bone health and mineral balance. Calcitriol, the active form of vitamin D3, plays a crucial role in calcium homeostasis by enhancing intestinal absorption of calcium and phosphate, thereby aiding in the prevention and treatment of hypocalcemia and metabolic bone diseases such as osteoporosis and rickets. Calcium Carbonate serves as a vital source of elemental calcium, essential for maintaining bone density, neuromuscular function, and vascular contraction. Zinc Sulfate contributes to enzymatic functions, immune response, and bone metabolism, facilitating tissue repair and growth. Gemsomax is indicated for patients with calcium and vitamin D deficiencies, those at risk of bone demineralization, and individuals requiring supplementation due to inadequate dietary intake or malabsorption syndromes. The softgel formulation ensures improved bioavailability and ease of administration. It is recommended to use Gemsomax under medical supervision, particularly in patients with renal impairment or hypercalcemia risk. Regular monitoring of serum calcium and renal function is advised during prolonged therapy to prevent adverse effects such as hypercalcemia or nephrolithiasis.